DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Kang SH, Lee YB, Lee JH. et al.
Rifaximin treatment is associated with reduced risk of cirrhotic complications and prolonged overall survival in patients experiencing hepatic encephalopathy.
Aliment Pharmacol Ther 2017;
46 (09) 845-855
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.